IP Library › Granted Patent US 8,372,450
Granted Patent B2
US 8,372,450 · App. 13/463,795 · Granted Feb 12, 2013

Chinese herbal composition for the treatment of macular degeneration and the process for manufacturing the same

Inventor: Jerry Yourui Wu (Mountain View, CA)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,450
App. No.
13/463,795
Granted
Feb 12, 2013
Kind
B2
Abstract

The present invention provides a Chinese herb composition for the treatment of macular degeneration and its preparation method. The composition comprises Salviae miltiorrhizae, Chuanxiong rhizoma, Lycii fructus, Chrysanthemi flos, Schisandrae chinensis fructus, Imperatae rhizoma , and Scutellariae radix , where the number of units by weight are: 0.8-3.0 units of Salviae miltiorrhizae , 0.3-2.0 units of Chuanxiong rhizoma , 0.6-2.4 units of Lycii fructus , 0.5-2.0 units of Chrysanthemi flos , 0.2-1.2 units of Schisandrae chinensis fructus , 0.9-6.0 units of Imperatae rhizoma , and 0.5-2.0 units of Scutellariae radix . The preparation method includes taking concentrated powder of each ingredient according to the number of units prescribed and mixing them together. The Chinese herb composition, conveniently delivered orally or parenterally, has been clinically proven to be safe and effective for all types of macular degeneration regardless of wet or dry forms.

Claims (20)

1. A Chinese herb composition for treating macular degeneration comprising: from about 0.8 to about 3.0 units by weight of Salviae miltiorrhizae , from about 0.3 to about 2.0 units by weight of Chuanxiong rhizoma , from about 0.6 to about 2.4 units by weight of Lycii fructus , from about 0.5 to about 2.0 units by weight of Chrysanthemi flos , from about 0.2 to about 1.2 units by weight of Schisandrae chinensis fructus , from about 0.9 to about 6.0 units by weight of Imperatae rhizoma , and from about 0.5 to about 2.0 units by weight of Scutellariae radix.

2. The Chinese herb composition according to claim 1 , wherein the Salviae miltiorrhizae is 2.0 units by weight, the Chuanxiong rhizoma is 1.0 unit by weight, the Lycii fructus is 2.0 units by weight, the Chrysanthemi flos is 0.5 units by weight, the Schisandrae chinensis fructus is 1.0 unit by weight, the Imperatae rhizoma is 2.0 units by weight, and the Scutellariae radix is 1.0 unit by weight.

3. The Chinese herb composition according to claim 1 , further comprising: Rehmanniae radix praeparata, Angelicae sinensis radix, Astragali radix, Dendrobii caulis, Cassiae semen, Plantaginis semen, Alismatis rhizoma, Forsythiae fructus, Puerariae lobatae radix, Poria , and Dipsaci radix.

4. The Chinese herb composition according to claim 3 , comprising: Salviae miltiorrhizae from about 0.8 to about 3.0 units by weight, Chuanxiong rhizoma from about 0.3 to about 2.0 units by weight, Lycii fructus from about 0.6 to about 2.4 units by weight, Chrysanthemi flos from about 0.5 to about 2.0 units by weight, Schisandrae chinensis fructus from about 0.2 to about 1.2 units by weight, Imperatae rhizoma from about 0.9 to about 6.0 units by weight, Scutellariae radix from about 0.5 to about 2.0 units by weight, Rehmanniae radix praeparata from about 0.7 to about 3.0 units by weight, Angelicae sinensis radix from about 0.4 to about 2.4 units by weight, Astragali radix from about 0.6 to about 6.0 units by weight, Dendrobii caulis from about 0.6 to about 2.4 units by weight, Cassiae semen from about 0.9 to about 3.0 units by weight, Plantaginis semen from about 0.6 to about 3.0 units by weight, Alismatis rhizoma from about 0.4 to about 1.8 units by weight, Forsythiae fructus from about 0.4 to about 3.0 units by weight, Puerariae lobatae radix from about 0.8 to about 3.0 units by weight, Poria from about 0.5 to about 3.0 units by weight, and Dipsaci radix from about 0.7 to about 3.0 units by weight, respectively.

5. The Chinese herb composition according to claim 3 , wherein the Salviae miltiorrhizae is 2.0 units by weight, the Chuanxiong rhizoma is 1.0 unit by weight, the Lycii fructus is 2.0 units by weight, the Chrysanthemi flos is 1.0 unit by weight, the Schisandrae chinensis fructus is 1.0 unit by weight, the Imperatae rhizoma is 2.0 units by weight, the Scutellariae radix is 1.0 unit by weight, the Rehmanniae radix praeparata is 2.0 units by weight, the Angelicae sinensis radix is 1.0 unit by weight, the Astragali radix is 2.0 units by weight, the Dendrobii caulis is 2.0 units by weight, Cassiae semen is 2.0 units by weight, the Plantaginis semen is 2.0 units by weight, the Alismatis rhizoma is 1.3 units by weight, the Forsythiae fructus is 1.3 units by weight, the Puerariae lobatae radix is 2.0 units by weight, the Poria is 2.0 units by weight, and the Dipsaci radix is 2.0 units by weight.

6. The Chinese herb composition according to claim 3 , further comprising Silybi fructus or Silybin.

7. The Chinese herb composition according to claim 4 , further comprising Silybi fructus from about 0.5 to about 3.0 units by weight.

8. The Chinese herb composition according to claim 4 , further comprising Silybin from about 0.035 to about 0.14 units by weight.

9. The Chinese herb composition according to claim 5 , further comprising 0.5 units by weight of Silybi fructus.

10. The Chinese herb composition according to claim 5 , further comprising 0.035 units by weight of Silybin.

11. The Chinese herb composition according to claim 1 , wherein said composition is administered orally.

12. The Chinese herb composition according to claim 1 , wherein said composition is in a form selected from the group consisting of a capsule, a tablet, a pill, a granulate, a pellet, a solid mixture, a dispersion in liquid phases, a suspension, an emulsion, a powder, a solution and a paste.

13. The Chinese herb composition according to claim 12 , wherein said composition is in a form selected from the group consisting of a suspension, an emulsion, a solution and a paste; and is administered parenterally.

14. A method for preparing the Chinese herb composition for treating macular degeneration of claim 1 , comprising the steps of:

obtaining a five-fold concentrated herb extract powder of each herbal component;

mixing evenly each of said concentrated herb extract powder according to said number of units by weight to form a mixed herb extract powder composition; and

placing said mixed herb extract powder composition into a form selected from the group consisting of tablets, pills, granulates, pellets, capsules, paper bags and plastic bags, solid mixtures, dispersions in liquid phases, suspensions, emulsions, solutions and pastes.

15. The method of claim 14 , wherein each of said capsules is a No. 0 sized capsule, wherein each of said capsules contains about 0.5 g of the mixed herb extract powder composition.

16. The method of claim 14 , wherein said paper bags are non-toxic medical paper bags, where each of said paper bags contains about 5.0 g of the mixed herb extract powder composition.

17. The method of claim 14 , wherein said plastic bags are opaque, non-toxic medical plastic bags, wherein each of said plastic bags contains about 5.0 g of the mixed herb extract powder composition.

Priority Claims (1)
CN 2011 1 0117394 · May 6, 2011 · national
Continuity (1)
Related Publication 20120282330A1 · Nov 8, 2012